The companies will work together to help pharmaceutical organizations improve efficiency and deliver better outcomes for patients. BOSTON, Jan. 13,…
Read More
WUXI, China, Jan. 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO),…
Read More